Monogram Orthopaedics, Inc.
MGRM · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $2 | $2 | $2 | $2 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $3 | $5 |
| Operating Income | -$3 | -$3 | -$3 | -$5 |
| % Margin | – | – | -686.1% | – |
| Other Income/Exp. Net | -$2 | $0 | -$1 | $0 |
| Pre-Tax Income | -$5 | -$3 | -$4 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$3 | -$4 | -$5 |
| % Margin | – | – | -998.7% | – |
| EPS | -0.16 | -0.096 | -0.13 | -0.16 |
| % Growth | -66.3% | 26% | 18.8% | – |
| EPS Diluted | -0.16 | -0.096 | -0.13 | -0.16 |
| Weighted Avg Shares Out | 36 | 35 | 33 | 32 |
| Weighted Avg Shares Out Dil | 36 | 35 | 33 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$3 | -$3 | -$5 |
| % Margin | – | – | -660.5% | – |